Marsh & McLennan Companies (NYSE:MMC – Get Free Report) released its earnings results on Thursday. The financial services provider reported $1.63 earnings per share for the quarter, topping the consensus estimate of $1.61 by $0.02, RTT News reports. Marsh & McLennan Companies had a net margin of 16.97% and a return on equity of 33.92%. The business had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.71 billion. During the same period last year, the firm posted $1.57 earnings per share. The firm’s quarterly revenue was up 5.9% compared to the same quarter last year.
Marsh & McLennan Companies Stock Up 0.8 %
Shares of MMC stock opened at $227.91 on Thursday. The stock has a 50 day moving average of $225.04 and a 200-day moving average of $214.68. The firm has a market cap of $112.30 billion, a PE ratio of 28.92, a price-to-earnings-growth ratio of 3.58 and a beta of 0.94. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.91. Marsh & McLennan Companies has a 12 month low of $184.02 and a 12 month high of $232.32.
Marsh & McLennan Companies Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 4th will be issued a $0.815 dividend. This represents a $3.26 dividend on an annualized basis and a yield of 1.43%. The ex-dividend date is Friday, October 4th. Marsh & McLennan Companies’s dividend payout ratio (DPR) is currently 41.37%.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Report on MMC
Insider Buying and Selling
In other Marsh & McLennan Companies news, CFO Mark C. Mcgivney sold 5,200 shares of the company’s stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $225.03, for a total value of $1,170,156.00. Following the completion of the transaction, the chief financial officer now owns 33,678 shares of the company’s stock, valued at $7,578,560.34. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other Marsh & McLennan Companies news, VP Stacy Mills sold 4,101 shares of the firm’s stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $225.77, for a total transaction of $925,882.77. Following the completion of the transaction, the vice president now owns 2,923 shares in the company, valued at $659,925.71. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Mark C. Mcgivney sold 5,200 shares of the company’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $225.03, for a total value of $1,170,156.00. Following the completion of the sale, the chief financial officer now owns 33,678 shares in the company, valued at approximately $7,578,560.34. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 19,566 shares of company stock valued at $4,420,137. 0.30% of the stock is owned by company insiders.
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies, Inc, a professional services company, provides advice and solutions to clients in the areas of risk, strategy, and people worldwide. It operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, and risk control and mitigation solutions, as well as insurance and reinsurance broking, strategic advisory services, and analytics solutions, and insurance program management services.
Read More
- Five stocks we like better than Marsh & McLennan Companies
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Should Warren Buffett’s Favorite Stock be Yours Too?
- Why is the Ex-Dividend Date Significant to Investors?
- Why Buffett Loves Occidental Stock And What It Means for Chevron
- What Are Dividend Challengers?
- UnitedHealth Group Pulls Back Into a Healthy Buying Opportunity
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.